Search research articles
Contact Us
Filters
Showing results (131-140 of 145) with videos related to
Page
of 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 5, 2025
Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohort
Andreu Vilaseca, Mar Tintoré, Pere Carbonell-Mirabent, et al.
JAMA Network Open
|
May 20, 2026
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity
René Carvajal, Marta Ponzano, Carmen Tur, et al.
Annals of Neurology
|
January 14, 2018
Deep gray matter volume loss drives disability worsening in multiple sclerosis
Arman Eshaghi, Ferran Prados, Wallace J Brownlee, et al.
Brain : a Journal of Neurology
|
June 10, 2026
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis
Carmen Tur, Silvia Susin-Calle, Susana Otero-Romero, et al.
Neurology
|
February 4, 2025
Age-Related Disability Outcomes After a First Demyelinating Event
Alvaro Cobo-Calvo, Pere Carbonell-Mirabent, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 9, 2024
Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies
René Carvajal, Breogán Rodríguez-Acevedo, Lorena García-Vasco, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 2, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
Ana Zabalza, Georgina Arrambide, Paula Tagliani, et al.
The Lancet. Infectious Diseases
|
January 13, 2024
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
Pau Bosch-Nicolau, Marisa L Fernández, Elena Sulleiro, et al.
Brain : a Journal of Neurology
|
May 10, 2018
Progression of regional grey matter atrophy in multiple sclerosis
Arman Eshaghi, Razvan V Marinescu, Alexandra L Young, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis
Manuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 145) with videos related to
Sort By:
Page
of 15
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 5, 2025
Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohort
Andreu Vilaseca, Mar Tintoré, Pere Carbonell-Mirabent, et al.
JAMA Network Open
|
May 20, 2026
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity
René Carvajal, Marta Ponzano, Carmen Tur, et al.
Annals of Neurology
|
January 14, 2018
Deep gray matter volume loss drives disability worsening in multiple sclerosis
Arman Eshaghi, Ferran Prados, Wallace J Brownlee, et al.
Brain : a Journal of Neurology
|
June 10, 2026
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis
Carmen Tur, Silvia Susin-Calle, Susana Otero-Romero, et al.
Neurology
|
February 4, 2025
Age-Related Disability Outcomes After a First Demyelinating Event
Alvaro Cobo-Calvo, Pere Carbonell-Mirabent, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 9, 2024
Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies
René Carvajal, Breogán Rodríguez-Acevedo, Lorena García-Vasco, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 2, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
Ana Zabalza, Georgina Arrambide, Paula Tagliani, et al.
The Lancet. Infectious Diseases
|
January 13, 2024
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
Pau Bosch-Nicolau, Marisa L Fernández, Elena Sulleiro, et al.
Brain : a Journal of Neurology
|
May 10, 2018
Progression of regional grey matter atrophy in multiple sclerosis
Arman Eshaghi, Razvan V Marinescu, Alexandra L Young, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis
Manuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Page
of 15